1H-PYRROLE-2-CARBOXYLIC ACID, 1-METHYL-5-NITRO-, METHYL ESTER, 95.0%, 1g

N-Acetyl-2-(4-nitrophenyl)ethylamine>98.0%(GC)25g

Acryloxypropyl T-structure siloxane, 10-30 cSt, 100g

(1S,2R)-2-((benzyloxy)carbonyl)cyclohexane-1-carboxylic acid, 98%, 100mg

1-[(4-bromophenyl)methyl]-1,4-diazepane, 95.0%, 1g

2-Chloro-4-methyl-5-nitro-pyridine, 97.0%, 10g

Tetrakis(4-cyanophenyl)ethylene, 97%, 1g

1-{4-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]piperidin-1-yl}ethan-1-one, %, 1g

(S)-Methyl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxypropanoate, 95.0%, 1g

Provette di eluizione ROTI® MIDI in soluzione stabilizzante, 5 Pezzo(i)

Benzonitrile, 2-[[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]methyl]-, 95%, 1g

(8aS)-8a-Methyl-3,4,8,8a-tetrahydronaphthalene-1,6(2H,7H)-dione, 99.0%, 5g

N-Methyl-1-(4-nitrophenyl)methanamine hydrochloride, 95.0%, 25g